Intra-individual variability in urinary losartan oxidation ratio, an in vivo marker of CYP2C9 activity

Lignende værker

• Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?
  af: Yasar, Umit
  Udgivet: (2018)
• Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population
  af: Scordo, Maria Gabriella, et al.
  Udgivet: (2001)
• Significantly lower CYP2D6 metabolism measured as the O/N‐desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients
  af: Haslemo, Tore, et al.
  Udgivet: (2018)
• Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity
  af: Zgheib, N K, et al.
  Udgivet: (2007)
• Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics
  af: Bae, Jung-woo, et al.
  Udgivet: (2011)